Heparin-binding exosite of factor Xa

Trends in Cardiovascular Medicine

Volumn 10, Issue 8, 2000, Pages 333-338

  Rezaie, Alireza R ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; CALCIUM; HEPARIN; PENTASACCHARIDE; POLYSACCHARIDE; PROTEINASE; THROMBIN;

ENZYME KINETICS; ENZYME SPECIFICITY; HUMAN; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW;

ANTITHROMBINS; CALCIUM; FACTOR VA; FACTOR XA; HEPARIN; HUMANS; MACROMOLECULAR SUBSTANCES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTHROMBIN; SUBSTRATE SPECIFICITY;

EID: 0034447287     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(01)00070-6     Document Type: Review

References (28)

1. Beguin S., Lindhout T., Hemker H.C. The mode of action of heparin in plasma. Thromb Haemostas. 60:1988;457-462.
2. Bode W., Mayr I., Baumann U.et al. The refined 1.9 Å crystal structure of human α-thrombin. interaction with D-Phe-Pro-Arg chlorometheylketone and significance of the Tyr-Pro-Pro-Trp insertion segment EMBO J. 8:1989;3467-3475.
3. Broze G.J., Girard T.J., Novotny W.F. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry. 29:1990;7539-7546.
4. Choay J., Petitou M., Lormeau J.-C.et al. Structural-activity relationship in heparin. a synthetic pentasaccharide with high-affinity for antithrombin III and eliciting high anti-factor Xa activity Biochem Biophys Res Commun. 116:1983;492-499.
5. Damus P.S., Hicks M., Rosenberg R.D. Anticoagulant action of heparin. Nature. 246:1973;355-357.
6. +-induced allosteric regulation of catalytic activity in serine proteases. Proc Natl Acad Sci USA. 93:1996;10,653-10,656.
7. de Agostini A.I., Watkins S.C., Slayter H.S.et al. Localization of anticoagulantly active heparin sulfate proteoglycans in vascular endothelium. antithrombin binding on cultured endothelial cells and perfused rat aorta J Cell Biol. 111:1990;1293-1304.
8. Furie B., Furie B.C. The molecular basis of blood coagulation. Cell. 53:1988;505-518.
9. Gan Z.-R., Li Y., Chen Z.et al. Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. J Biol Chem. 269:1994;1301-1305.
10. Girard T.J., Warren L.A., Novotny W.F.et al. Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. Nature. 338:1989;518-520.
11. He X., Ye J., Esmon C.T., Rezaie A.R. Influence of arginine 93, 97, and 101 of thrombin to its functional specificity. Biochemistry. 36:1997;8969-8976.
12. Leytus S.P., Foster D.C., Kurachi K., Davie E.W. Gene for human factor X. A blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C Biochemistry. 25:1986;5098-5102.
13. Mann K.G., Jenny R.J., Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annu Rev Biochem. 57:1988;915-956.
14. Marcum J.A., Rosenberg R.D. Anticoagulantly active heparin-like molecules from the vascular tissue. Biochemistry. 23:1984;1730-1737.
15. Mathur A., Bajaj S.P. Protease and EGF1 domains of factor IXa play distinct roles in binding to factor VIIIa. J Biol Chem. 274:1999;18,477-18,486.
16. Olson ST, Björk I: 1992. Regulation of thrombin by antithrombin and heparin cofactor II. In Berliner LJ, ed. Thrombin: Structure and Function. New York, Plenum Press, p. 159.
17. Olson S.T., Björk I. Mechanism of action of heparin and heparin-like antithrombotics. Prosp Drug Discov Design. 1:1993;479-501.
18. Olson S.T., Björk I., Sheffer R.et al. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem. 267:1992;12,528-12,538.
19. Padmanabhan K., Padmanabhan K.P., Tulinsky A.et al. Structure of human des (1-45) factor Xa at 22 Å resolution. J Mol Biol. 232:1993;947-966.
20. Rezaie A.R. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by a template mechanism. Evidence that calcium alleviates Gla-domain antagonism of heparin binding to factor Xa. J Biol Chem. 273:1998;16,824-16,827.
21. Rezaie A.R. Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding. J Biol Chem. 275:2000;3320-3327.
22. 2+ binding site yet retains function. J Biol Chem. 269:1994;21,495-21,499.
23. Rezaie A.R., He X. Sodium binding site of factor Xa. role of sodium in the prothrombinase complex Biochemistry. 39:2000;1817-1825.
24. Rezaie A.R., Neuenschwander P.F., Morrissey J.H., Esmon C.T. Analysis of the functions of the first epidermal growth factor-like domain of factor X. J Biol Chem. 268:1993;8176-8180.
25. Rezaie A.R., Olson S.T. Calcium enhances heparin catalysis of the antithrombin-factor Xa reaction by promoting the assembly of an intermediate heparin-antithrombin-factor Xa binding complex. Demonstration by rapid kinetics studies. Biochemistry. 39:2000;12,083-12,090.
26. Sheehan J.P., Sadler J.E. Molecular mapping of the heparin-binding exosite of thrombin. Proc Natl Acad Sci USA. 91:1994;5518-5522.
27. Stenflo J. Structure-function relationships of epidermal growth factor modules in vitamin K-dependent clotting factors. Blood. 78:1991;1637-1651.
28. Streusand V.J., Björk I., Gettins P.G.W.et al. Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. J Biol Chem. 270:1995;9043-9051.